Costs, throughput time, and proportion of valid test results, a model-based analysis of liquid biopsies for stage IV non-small cell lung cancer.

被引：0
|
作者：
Koole, Simone N.
Schouten, Robert
Vessies, Daan
Schuurbiers, Milou
Bosch, Linda J. W.
van den Heuvel, Michel
van Harten, Wim
van den Broek, Daan
Monkhorst, Kim
Retel, Valesca P.
机构：
[1] Netherlands Canc Inst, Dept Hlth Econ, Amsterdam, Netherlands
[2] Netherlands Canc Inst, Amsterdam, Netherlands
[3] Radboud Univ, Med Ctr, Nijmegen, Netherlands
[4] Netherlands Canc Inst, Dept Pathol, Amsterdam, Netherlands
[5] RadboudUMC, Dept Thorac Oncol, Nijmegen, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e18844
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18844
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Effect of time to treatment on survival in non-small cell lung cancer.
    Anggondowati, Trisari
    Ganti, Apar Kishor
    Watanabe-Galloway, Shinobu
    Haynatzki, Gleb
    Islam, K. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [42] Patterns of referral to palliative care in clinical practice in patients with stage IV non-small cell lung cancer.
    Karim, Safiya
    Ahmed, Shahid
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (31)
  • [43] Patterns of disease progression to checkpoint inhibitor immunotherapy in patients with stage IV non-small cell lung cancer.
    Fei, Naomi
    Attia, Christina
    Almubarak, Mohammed
    Ma, Patrick C.
    Mattes, Malcolm David
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [44] Treatment standards and Perspectives in non-small cell Lung cancer in stage IV
    Reck, Martin
    Rosell, Rafael
    Tiemann, Markus
    ONKOLOGIE, 2012, 35 : 10 - 13
  • [45] SPIROMETRY IN PATIENTS WITH STAGE IV NON-SMALL CELL LUNG CANCER (NSCLC)
    Mendis, R.
    McDonald, C. F.
    John, T.
    O'Donoghue, F. J.
    White, S. C.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S75 - S75
  • [46] Stage IV Non-small Cell Lung Cancer Presenting as Supraventricular Tachycardia
    Amin, Hina
    Chaudhuri, Debanik
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (04)
  • [47] Prognostic factors in patients with stage IV non-small cell lung cancer
    Meili Ma
    The Chinese-German Journal of Clinical Oncology, 2006, (05) : 319 - 323
  • [48] Chemotherapeutic inroads in treating stage IV non-small cell lung cancer
    Langer, CJ
    CURRENT PROBLEMS IN CANCER, 1996, 20 (04) : 221 - 246
  • [49] Treatment of stage IV non-small cell lung cancer with driver mutations
    Michels, Sebastian
    Wolf, Juergen
    ONKOLOGE, 2018, 24 (12): : 983 - 991
  • [50] Early detection of non-small cell lung cancer in liquid biopsies by ultrasensitive protease activity analysis
    Udukala, Dinusha N.
    Wendel, Sebastian O.
    Wang, Hongwang
    Yapa, Asanka S.
    Covarrubias-Zambrano, Obdulia
    Janik, Katharine
    Gadbury, Gary
    Troyer, Deryl L.
    Bossmann, Stefan H.
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2020, 6
12345